Letter: Arsenic and non-cirrhotic portal hypertension

Impairment of drug elimination in patients with liver disease.

International journal of clinical pharmacology, therapy, and toxicology·1985

In vitro drug metabolism in humans with different liver diseases.

International journal of clinical pharmacology, therapy, and toxicology·1983

Levels of arsenic in liver cirrhosis.

Toxicology letters·1983

Lymphocyte subpopulation in acute viral hepatitis.

Gut·1982

Impairment of hepatic drug metabolism in patients with acute viral hepatitis.

European journal of drug metabolism and pharmacokinetics·1982

Antipyrine clearance, aminopyrine N-demethylase, and bilirubin UDP-glucuronyl transferase activity in patients with amoebic liver abscess.

Biopharmaceutics & drug disposition·1982

Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study.

Lancet (London, England)·2026

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

Lancet (London, England)·2026

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Lancet (London, England)·2026

Molecular hydrogen: a potential guardian against environmental radiation damage.

Medical gas research·2026

Hydrogen-rich water combined with traditional Chinese medicine compound in the treatment of kidney stones: a randomized controlled prospective clinical trial.

Medical gas research·2026

Humic acid promotes Fe(II) dynamics and hydroxyl radical generation via interfacial regulation on nanoscale zerovalent iron for imidacloprid degradation.

Water research·2026

The antibiotic NAB815 does not induce SOS response and toxin production in Shiga toxin-producing Escherichia coli at sub-bactericidal concentrations.

International journal of medical microbiology : IJMM·2026

Molecular dynamics simulation of perfluorohexanone-based synergistic gas mixtures and mechanistic prediction of hydrogen fluoride formation pathways.

Journal of molecular modeling·2026

Normal human synovial fluid exhibits stable hyaluronic acid and proteoglycan 4 levels across age and sex.

Osteoarthritis and cartilage open·2026

Related Experiment Videos

Letter: Arsenic and non-cirrhotic portal hypertension

Related Concept Videos

Impairment of drug elimination in patients with liver disease.

In vitro drug metabolism in humans with different liver diseases.

Levels of arsenic in liver cirrhosis.

Lymphocyte subpopulation in acute viral hepatitis.

Impairment of hepatic drug metabolism in patients with acute viral hepatitis.

Antipyrine clearance, aminopyrine N-demethylase, and bilirubin UDP-glucuronyl transferase activity in patients with amoebic liver abscess.

Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study.

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Molecular hydrogen: a potential guardian against environmental radiation damage.

Hydrogen-rich water combined with traditional Chinese medicine compound in the treatment of kidney stones: a randomized controlled prospective clinical trial.

Humic acid promotes Fe(II) dynamics and hydroxyl radical generation via interfacial regulation on nanoscale zerovalent iron for imidacloprid degradation.

The antibiotic NAB815 does not induce SOS response and toxin production in Shiga toxin-producing Escherichia coli at sub-bactericidal concentrations.

Molecular dynamics simulation of perfluorohexanone-based synergistic gas mixtures and mechanistic prediction of hydrogen fluoride formation pathways.

Normal human synovial fluid exhibits stable hyaluronic acid and proteoglycan 4 levels across age and sex.

Related Experiment Videos

Letter: Arsenic and non-cirrhotic portal hypertension

Related Concept Videos

Related Articles